At the upcoming inaugural Cancer Summit, the community will have a unique
opportunity to hear from Huntsman Cancer Institute (HCI) at the University
of Utah and St. John's Medical Center (SJMC) specialists about new
cancer treatment breakthroughs, what's on the horizon, and what patients
can expect from recent advances in cancer care. The event will be held
on Thursday, June 29, from 7 to 8 pm, in the Jackson Room at the Wort Hotel.
HCI medical oncologist Kenneth Grossmann, MD, PhD, will be the keynote
speaker, focusing on clinical trials and treatment advances in immunotherapy.
Immunotherapy is the use of medicines to stimulate a person's own
immunity system to recognize and destroy cancer cells more effectively.
In recent years, HCI’s immunotherapy research and clinical trials
have opened new doors for treating some cancers as an alternative or adjunct
treatment for traditional care involving chemotherapy and radiation.
"One of the exciting opportunities that our affiliation with HCI offers
is community and clinical education on important medical topics,"
said SJMC communications officer Karen Connelly. "We are very pleased
to bring a top researcher to Jackson Hole to speak to patients, hospital
staff, and our intellectually curious community."
Dr. Grossmann is a medical oncologist with HCI's Melanoma Program
and an assistant professor of medicine at the University of Utah. His
laboratory research focuses on a demethylase enzyme that can cause the
hallmarks of many kinds of cancer, including melanoma. Additionally, he
focuses on understanding other signaling pathways in melanoma tumors and
developing methods to overcome resistance to targeted therapies.
Ben Tanner, MHA, executive director of the cancer hospital at HCI, will
begin the program with remarks about the affiliation agreement between
HCI and SJMC.
Following Dr. Grossmann's presentation, the Summit will feature a
panel of physicians from the HCI and SJMC medical staff who regularly
care for cancer patients in their specific medical specialty. The panel
will be facilitated by SJMC CEO Dr. Paul Beaupre, and the focus will be
on the pathways available for care for St. John's cancer patients,
including how local specialists work together and coordinate care with
HCI and other cancer centers.
Panelists will include Dr. John Ward, hematologist/oncologist; Dr. Ryan
Bair, radiation oncologist; Dr. Randy Kjorstad, general surgeon; Dr. Maura
Lofaro, OB/GYN; Dr. Martin Trott, ENT; Dr. Lars Conway, pathologist; and
Dr. Sean Haling, radiologist.
Suzanne Young, Marketing Manager, University of Utah Health, (801) 661-4609,
Karen Connelly, Chief Marketing Officer, St. John’s Medical Center,
307 739 7380, firstname.lastname@example.org
ABOUT ST. JOHN’S MEDICAL CENTER
St. John's Medical Center in Jackson, Wyoming, offers patient-centered
clinical excellence and community wellness services through a full-service
hospital, primary care, and specialty physician practices, and a long-term
care Living Center.
ABOUT HUNTSMAN CANCER INSTITUTE
Huntsman Cancer Institute's mission is to understand cancer from its
beginnings, to use that knowledge in the creation and improvement of cancer
treatments, to relieve the suffering of cancer patients, and to provide
education about cancer risk, prevention, and care.
ABOUT UNIVERSITY OF UTAH HEALTH CARE
University of Utah Health Care is the Intermountain West’s only
academic health care system, combining excellence in patient care, the
latest in medical research, and teaching to provide leading-edge medicine
in a caring and personal setting. The system provides care for Utahns
and residents of five surrounding states in a referral area encompassing
more than 10 percent of the continental United States.
ABOUT ST. JOHN’S HOSPITAL FOUNDATION
The mission of the St. John’s Hospital Foundation is to secure philanthropic
support to advance the mission and strategic objectives of St. John’s
Medical Center, including patient-centered care, clinical excellence,
and community wellness. For more information, visit www.stjohnshospitalfoundation.org